Similar Search Results

Kostnadseffektivitetsanalyser : ett instrument för en långsiktigt hållbar läkemedelsmarknad?

Persson, Ulf; Nordling, Sara; Pettersson, Billie - In: Ekonomisk debatt 37 (2009) 3, pp. 42-53

Persistent link: https://www.econbiz.de/10003834375

Regulations - pricing policies

Kumar, B. Rajesh; Satish, S. M. - In: Indian pharmaceutical industry : strategies and …, (pp. 38-49). 2008

Persistent link: https://www.econbiz.de/10003852051

Der Effekt von Parallelhandel auf die regulierten Medikamentenpreise

Weder, Rolf; Schläpfer, Alain - 2009

Die Frage der Zulassung von Parallelimporten von patentierten Gütern wird in der Schweiz kontrovers diskutiert. Medikamente stellen dabei einen Spezialfall der Güter mit Patentschutz dar, da die Preise für Medikamente in allen westlichen Ländern durch staatliche Behörden direkt oder...

Persistent link: https://www.econbiz.de/10003891807

Pharmaceutical pricing and reimbursement policies in Mexico

Moi͏̈se, Pierre (contributor); … - 2007

Persistent link: https://www.econbiz.de/10003420529

The national regulation of pharmaceutical markets and the timing of new drug launches in Europe

Heuer, Alexander (contributor); Mejer, Malwina (contributor) - 2007

, pharmaceutical companies, by acting strategically, may further increase launch delays. -- pharmaceuticals ; regulation ; new chemical …

Persistent link: https://www.econbiz.de/10003471161

Price regulation and generic competition in the pharmaceutical market

Dalen, Dag Morten; Strøm, Steinar; Haabeth, Tonje - In: The European journal of health economics : HEPAC ; … 7 (2006) 3, pp. 208-214

Persistent link: https://www.econbiz.de/10003378742

Advertising, generic competition and price regulation in pharmaceutical markets

Königbauer, Ingrid - In: CESifo economic studies : CESifo, a joint initiative of … 52 (2006) 3, pp. 565-586

The effect of price regulation on generic market entry and welfare in the presence of (persuasive) advertising is analysed. An incumbent has the possibility to invest in advertising targeted at the physician. Advertising creates vertical product differentiation between brand-name drugs and its...

Persistent link: https://www.econbiz.de/10003379146

Patentgeschützte Arzneimittel im Regulierungsdickicht des Arzneimittelmarktneuordnungsgesetzes

Jaeckel, Roger; Kunz, Angelika R. - In: Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen, (pp. 239-250). 2011

Persistent link: https://www.econbiz.de/10008859748

Germany's struggle with prices for patent-protected drugs

Kifmann, Mathias; Neelsen, Sven - In: CESifo DICE report : journal for institutional comparisons 8 (2010) 3, pp. 43-52

Persistent link: https://www.econbiz.de/10008702709

Eliminating drug price differentials across government programmes in the USA

Chalkidou, Kalipso; Anderson, Gerard F.; Faden, Ruth - In: Health economics, policy and law 6 (2011) 1, pp. 43-64

Persistent link: https://www.econbiz.de/10008855856